Skip to Main Content

Author Details

Elizabeth Stewart
St Jude Children's Research Hospital
2006
64
25
Nathan Sheffield (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
37441939Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.Eur J Cancer2023
37441939Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.Eur J Cancer2023
34871104Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A.J Clin Oncol2022
35483358The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma.Dev Cell2022
36636325Alzheimer's disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment.Nat Aging2022
35119937Antigen cross-presentation in young tumor-bearing hosts promotes CD8<sup>+</sup> T cell terminal differentiation.Sci Immunol2022
34871104Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu14.18K322A.J Clin Oncol2022
35483358The myogenesis program drives clonal selection and drug resistance in rhabdomyosarcoma.Dev Cell2022
36636325Alzheimer's disease-associated U1 snRNP splicing dysfunction causes neuronal hyperexcitability and cognitive impairment.Nat Aging2022
35119937Antigen cross-presentation in young tumor-bearing hosts promotes CD8<sup>+</sup> T cell terminal differentiation.Sci Immunol2022
33326105Orthotopic Implants in Mice.Methods Mol Biol2021
34137164Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force.Pediatr Blood Cancer2021
34315877Retinoblastoma from human stem cell-derived retinal organoids.Nat Commun2021
33915882Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force.J Clin Med2021
33326105Orthotopic Implants in Mice.Methods Mol Biol2021
34782706Methylation profiling reveals novel molecular classes of rhabdomyosarcoma.Sci Rep2021
34753908The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma.Nat Commun2021
33915882Prioritization of Novel Agents for Patients with Rhabdomyosarcoma: A Report from the Children's Oncology Group (COG) New Agents for Rhabdomyosarcoma Task Force.J Clin Med2021
34753908The chemotherapeutic CX-5461 primarily targets TOP2B and exhibits selective activity in high-risk neuroblastoma.Nat Commun2021
34782706Methylation profiling reveals novel molecular classes of rhabdomyosarcoma.Sci Rep2021
34315877Retinoblastoma from human stem cell-derived retinal organoids.Nat Commun2021
34137164Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force.Pediatr Blood Cancer2021
32795876A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies.Eur J Cancer2020
32795876A phase I trial of talazoparib and irinotecan with and without temozolomide in children and young adults with recurrent or refractory solid malignancies.Eur J Cancer2020
30395907Combinatorial screening using orthotopic patient derived xenograft-expanded early phase cultures of osteosarcoma identify novel therapeutic drug combinations.Cancer Lett2019
31601569A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma.Clin Cancer Res2019
31631027ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures.Cancer Cell2019
30395907Combinatorial screening using orthotopic patient derived xenograft-expanded early phase cultures of osteosarcoma identify novel therapeutic drug combinations.Cancer Lett2019
31031965Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children's Oncology Group (COG) New Agents for Ewing Sarcoma Task Force.F1000Res2019
31222885Insights into pediatric rhabdomyosarcoma research: Challenges and goals.Pediatr Blood Cancer2019
31015228Positron Emission Tomography Detects <i>In Vivo</i> Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma.Cancer Res2019
31601569A Phase II Trial of Hu14.18K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma.Clin Cancer Res2019
31631027ATRX In-Frame Fusion Neuroblastoma Is Sensitive to EZH2 Inhibition via Modulation of Neuronal Gene Signatures.Cancer Cell2019
31222885Insights into pediatric rhabdomyosarcoma research: Challenges and goals.Pediatr Blood Cancer2019
31015228Positron Emission Tomography Detects <i>In Vivo</i> Expression of Disialoganglioside GD2 in Mouse Models of Primary and Metastatic Osteosarcoma.Cancer Res2019
31031965Emerging novel agents for patients with advanced Ewing sarcoma: a report from the Children's Oncology Group (COG) New Agents for Ewing Sarcoma Task Force.F1000Res2019
29350222A Prescription for Note Bloat: An Effective Progress Note Template.J Hosp Med2018
30146332Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses.Cancer Cell2018
29350222A Prescription for Note Bloat: An Effective Progress Note Template.J Hosp Med2018
29769641Erratum: BRAID: A Unifying Paradigm for the Analysis of Combined Drug Action.Sci Rep2018
30146332Identification of Therapeutic Targets in Rhabdomyosarcoma through Integrated Genomic, Epigenomic, and Proteomic Analyses.Cancer Cell2018
29769641Erratum: BRAID: A Unifying Paradigm for the Analysis of Combined Drug Action.Sci Rep2018
28854174Orthotopic patient-derived xenografts of paediatric solid tumours.Nature2017
28349774Increasing Ketamine Use for Refractory Status Epilepticus in US Pediatric Hospitals.J Child Neurol2017
28854174Orthotopic patient-derived xenografts of paediatric solid tumours.Nature2017
28349774Increasing Ketamine Use for Refractory Status Epilepticus in US Pediatric Hospitals.J Child Neurol2017
26068307The Childhood Solid Tumor Network: A new resource for the developmental biology and oncology research communities.Dev Biol2016
27441585A Case Study: Analyzing City Vitality with Four Pillars of Activity-Live, Work, Shop, and Play.Big Data2016
26807878Effect of Base-Pairing Partner on the Thermodynamic Stability of the Diastereomeric Spiroiminodihydantoin Lesion.Chem Res Toxicol2016
26802024The second European interdisciplinary Ewing sarcoma research summit--A joint effort to deconstructing the multiple layers of a complex disease.Oncotarget2016
  • 1 - 50 of 128

Recommended Authors

Chelsea Mayoh
Children's Cancer Institute, Lowy Cancer Research Centre
Career Start Year 2016
Number of shared co-authors 8
Noah E Berlow
Children's Cancer Therapy Development Institute
Career Start Year 2011
Number of shared co-authors 7
Nehme El-Hachem
Centre Hospitalier Universitaire Sainte-Justine Research Centre
Career Start Year 2011
Number of shared co-authors 0
Dylan Nelson
Oregon State University
Career Start Year 2011
Number of shared co-authors 0
Donald A Barkauskas
Keck School of Medicine of the University of Southern California
Career Start Year 2009
Number of shared co-authors 16
Subha Madhavan
Innovation Center for Biomedical Informatics, Georgetown University Medical Center
Career Start Year 2009
Number of shared co-authors 6
Pankaj Vats
Michigan Center for Translational Pathology, University of Michigan ann arbor
Career Start Year 2008
Number of shared co-authors 3
James R Whittle
Walter and Eliza Hall Institute of Medical Research
Career Start Year 2006
Number of shared co-authors 0
Julia Carnevale
University of California san francisco
Career Start Year 2006
Number of shared co-authors 1
Pichai Raman
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2006
Number of shared co-authors 15
Annette Bakker
Children's Tumor Foundation
Career Start Year 2004
Number of shared co-authors 2
Olivier Elemento
Meyer Cancer Center
Career Start Year 2002
Number of shared co-authors 2
Syed Haider
Institute of Cancer Research
Career Start Year 2002
Number of shared co-authors 1
Adam C Resnick
Center for Data-Driven Discovery in Biomedicine, Children's Hospital of Philadelphia
Career Start Year 2001
Number of shared co-authors 19
Dexiang Gao
University of Colorado Anschutz Medical Campus
Career Start Year 2001
Number of shared co-authors 0
Eric W Klee
Mayo Clinic College of Medicine and Science
Career Start Year 2001
Number of shared co-authors 1
Pingfu Fu
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 0
Samuel L Volchenboum
University of Chicago
Career Start Year 1998
Number of shared co-authors 14
Alex Kentsis
Memorial Sloan-Kettering Cancer Center
Career Start Year 1998
Number of shared co-authors 2
Elizabeth Garrett-Mayer
Center for Research and Analytics, American Society of Clinical Oncology
Career Start Year 1997
Number of shared co-authors 0
Dongquan Chen
University of Alabama at Birmingham
Career Start Year 1997
Number of shared co-authors 0
Nam Bui
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Yongjin Li
Mayo Clinic
Career Start Year 1995
Number of shared co-authors 27
Kristina A Cole
Perelman School of Medicine, University of Pennsylvania
Career Start Year 1994
Number of shared co-authors 6
Christopher P Austin
St. George's University Medical School
Career Start Year 1990
Number of shared co-authors 2
Todd R Golub
Broad Institute of MIT and Harvard
Career Start Year 1989
Number of shared co-authors 16
Luigi Marchionni
Weill-Cornell School of Medicine
Career Start Year 1989
Number of shared co-authors 2
David M Loeb
Children's Hospital at Montefiore.
Career Start Year 1986
Number of shared co-authors 12
Phuong Nguyen
Hoag Memorial Hospital Presbyterian
Career Start Year 1983
Number of shared co-authors 3
Stephen H Friend
University of Oxford
Career Start Year 1978
Number of shared co-authors 3

Collaborators

Eugene Kolker
Co-authored papers 24
Natali Kolker
Co-authored papers 15
Roger Higdon
Co-authored papers 15
Alberto S Pappo
St Jude Children's Research Hospital
Co-authored papers 13
Anang A Shelat
St. Jude Children's Research Hospital
Co-authored papers 12
Larissa Stanberry
Co-authored papers 8
Xiang Chen
St. Jude Children's Research Hospital
Co-authored papers 8
Elizabeth Montague
Co-authored papers 8
Imre Janko
Co-authored papers 7
John Choiniere
Co-authored papers 7
Vural Ozdemir
Co-authored papers 6
Gregory Yandl
Co-authored papers 5
Nathaniel Anderson
Co-authored papers 5
Peter J Houghton
The University of Texas Health Science Center at San Antonio
Co-authored papers 4
Xin Zhou
St. Jude Children's Research Hospital
Co-authored papers 4
Elaine Lee
Co-authored papers 4
Douglas S Hawkins
Co-authored papers 4
Charles V Smith
Co-authored papers 4
John Easton
St Jude Children's Research Hospital
Co-authored papers 4
Courtney MacNealy-Koch
Co-authored papers 3
Brent A Orr
St. Jude Children's Research Hospital
Co-authored papers 3
Amos Hong Pheng Loh
Co-authored papers 3
Richard K Wilson
The Ohio State University
Co-authored papers 3
Elaine R Mardis
The Ohio State University
Co-authored papers 3
Doron Lancet
Co-authored papers 3
Patrick J Grohar
Children's Hospital of Philadelphia.
Co-authored papers 3
Todd Smith
Co-authored papers 3
Lennart Martens
Co-authored papers 3
Jinghui Zhang
Changhai Hospital, Second Military Medical University
Co-authored papers 3
William S Hancock
Northeastern University
Co-authored papers 2
Release 1.2